Oncoimmunin is a biotechnology company based in Gaithersburg, MD, specializing in the development of innovative immunotherapy treatments for cancer. The company's research focuses on harnessing the power of the immune system to target and destroy cancer cells.
With a team of dedicated scientists and experts in the field, Oncoimmunin is committed to advancing the field of cancer immunotherapy and improving outcomes for patients. Through cutting-edge research and collaboration with leading institutions, Oncoimmunin aims to revolutionize cancer treatment and make a meaningful impact on the lives of those affected by the disease.
Generated from their business information